CyanoCapture
CyanoCapture is a biotech company focused on photosynthetic biomanufacturing, utilizing genetically engineered cyanobacteria powered by sunlight and fed on CO2 to synthesize high-value biomolecules. Their mission is to revolutionize drug manufacturing and industrial processes by providing low-energy, biological synthesis methods that are scalable and environmentally friendly. They aim to turn CO2 into valuable products, reducing emissions and creating economic opportunities.
Industries
Nr. of Employees
small (1-50)
Products
IFN-Alpha (photosynthetically produced)
Recombinant interferon-alpha produced via photosynthetic biomanufacturing from engineered cyanobacterial strains.
FGF2 (recombinant growth factor)
Fibroblast growth factor 2 produced via engineered photosynthetic microbes intended for research or therapeutic applications.
Peptide therapeutics (pipeline)
Peptide-based drug candidates produced via the photosynthetic platform; pipeline includes announced peptide product(s) and additional pharmaceutical candidates.
Industrial enzymes
Enzymes produced from engineered photosynthetic microbes for industrial applications.
Bioplastics and bio-graphite
Materials streams derived from processed cyanobacterial biomass intended for use as bioplastics or bio-derived graphite substitutes.
Biocrude oil and biochar
Upstream biomass conversion products including biocrude and biochar generated from processed cyanobacterial biomass.
IFN-Alpha (photosynthetically produced)
Recombinant interferon-alpha produced via photosynthetic biomanufacturing from engineered cyanobacterial strains.
FGF2 (recombinant growth factor)
Fibroblast growth factor 2 produced via engineered photosynthetic microbes intended for research or therapeutic applications.
Peptide therapeutics (pipeline)
Peptide-based drug candidates produced via the photosynthetic platform; pipeline includes announced peptide product(s) and additional pharmaceutical candidates.
Industrial enzymes
Enzymes produced from engineered photosynthetic microbes for industrial applications.
Bioplastics and bio-graphite
Materials streams derived from processed cyanobacterial biomass intended for use as bioplastics or bio-derived graphite substitutes.
Biocrude oil and biochar
Upstream biomass conversion products including biocrude and biochar generated from processed cyanobacterial biomass.
Services
Design, installation and operation of photobioreactor systems integrated into point-source emission sites for CO2 capture and on-site biomanufacturing of biomass and target compounds.
Execution of pilot and demonstration projects at 1,000 L and multi-thousand litre scale with support for scaling to 20,000 L and beyond, including continuous cultivation experiments and productivity characterisation.
Licensing of engineered strains, cloning methods and related intellectual property for partners and customers seeking access to photosynthetic biomanufacturing capabilities.
Contracted supply agreements for produced biomolecules from planned scale-up facilities, with announced early-stage fixed-price offers for initial customers.
Design, installation and operation of photobioreactor systems integrated into point-source emission sites for CO2 capture and on-site biomanufacturing of biomass and target compounds.
Execution of pilot and demonstration projects at 1,000 L and multi-thousand litre scale with support for scaling to 20,000 L and beyond, including continuous cultivation experiments and productivity characterisation.
Licensing of engineered strains, cloning methods and related intellectual property for partners and customers seeking access to photosynthetic biomanufacturing capabilities.
Contracted supply agreements for produced biomolecules from planned scale-up facilities, with announced early-stage fixed-price offers for initial customers.
Expertise Areas
- Photosynthetic biomanufacturing
- Cyanobacterial strain engineering
- Photobioreactor deployment and integration
- Carbon capture and utilization (CCU)
Key Technologies
- Photobioreactors (closed tubular PBR systems)
- CRISPR gene editing
- Strain engineering and synthetic biology libraries
- Continuous cultivation and automated harvest systems
News & Updates
CyanoCapture has secured $4 million for the COSEC project in Portugal, focusing on carbon capture and utilization.
A successful demonstration of direct CO2 capture from a customer's methanol combustion unit using cyanobacteria in a photobioreactor.
The UK’s H2Boost project employs dark fermentation and algae to convert organic waste into biohydrogen and capture emissions.
CyanoCapture uses altered algal genomes to grow high-metabolism strains of cyanobacteria that capture CO2 more efficiently, as reported in the ACS journal.
Winner of Elon Musk’s XPRIZE 2021
Winner of Shell New Energy Challenge 2023
CyanoCapture has secured $4 million for the COSEC project in Portugal, focusing on carbon capture and utilization.
A successful demonstration of direct CO2 capture from a customer's methanol combustion unit using cyanobacteria in a photobioreactor.
The UK’s H2Boost project employs dark fermentation and algae to convert organic waste into biohydrogen and capture emissions.
CyanoCapture uses altered algal genomes to grow high-metabolism strains of cyanobacteria that capture CO2 more efficiently, as reported in the ACS journal.